
A new meta-analysis of 48 studies with 17,188 participants reveals that combination therapies outperform monotherapies for moderate-to-severe allergic rhinitis. The intranasal antihistamine (INAH) and intranasal corticosteroid (INCS) combo was most effective, though it carried a risk of bitter taste. Oral antihistamines (OAH) with INCS offer a strong alternative, paving the way for personalized treatments.
Like
Save
Share